{"name":"Imugene Limited","slug":"imugene-limited","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi2AFBVV95cUxObGx6NDJvTXliRWw2MXpDWUlzektKU3V4bjBsVWtVOElCdXdNSXN5anpfdFhDdjNZX2pXRkw5LWp0ZHNLcjBoT3ZUU25FdXZraVI3RDMzbHdkZU9GeUNzNG0tMGJFNU5TbXhkc19wNE1MT2tHQzUtaE5oX1BrMVNPVEk5UzFzaWlUMjlBYmROakZTdm9jdXNHUXFKS2FtZXQydEJkWHhEaGJLNzQ1UHNMTXJfbEpZblZ1V3dzZjFXWGdlZzEwRU1aRHduODZLRElJbVBZUkx3TXE?oc=5","date":"2026-02-27","type":"trial","source":"Proactive financial news","summary":"Imugene to showcase azer-cel data at major US healthcare conference | ASX:IMU, OTC:IUGNF - Proactive financial news","headline":"Imugene to showcase azer-cel data at major US healthcare conference | ASX:IMU, OTC:IUGNF","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0AFBVV95cUxQQzZVVXVJRy10b2FiMGRwbEpFTUlKd0EyQlNrdTRZRXJPZGZ6aXg5QmpkX1lZeTlPUzVKMnI5TE5CMHl2NkJYT3M4U1lMZ2R3YmR5LUVlbkZGNlAzTUpBN1ZBX2ttaldnLV9WMEZ4NDR5V0U2SkFfTE13XzNqS3UwZ1ZPY0ltNGg3Sm54R3VpZ1VZSXJjS3hlNDlmbUhuQnEzd2lIRzgtRWVLUXhJcFFPeVNzc1ZQTGo0ZHExOVhPTFFRSHF2Y1dpTVhmWjRYc1lU?oc=5","date":"2026-02-24","type":"pipeline","source":"Proactive financial news","summary":"Imugene secures $2.7m R&D tax refund to support clinical programs | ASX:IMU, OTC:IUGNF - Proactive financial news","headline":"Imugene secures $2.7m R&D tax refund to support clinical programs | ASX:IMU, OTC:IUGNF","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgJBVV95cUxOQTR0d1l3a3B2VmdFdjY0QkJVZ01rYmtPV0gtNERtMXMyN1lXdTdpOTFRRjFjREFaSENvbDByU2JUdzRVZ2Mxc3dsbU8zYm5MUElhVGl3RHkyU3NzaTZ5b3U2T1NOUGlUaE90MDNtUTB1Z2xIeWRSZ1NfTEpwU1hzcDZiZnpYX0puU1lTZmYyMDZ6YS02YnowdU1jbU1wZmh0d3pYNmpiYV9VVnpzTXRva09wdE9RUzZ1d3dWOGtVMGJwVmFaVkJndlJMM09oSWRhUWZKVUJJSW1iSXBWc0p5bm83ZlZOYmxaZXdEOG1ZZHZib2pxcUltWmFrdjJha0JhRFNKYTF3QlFjd0hEN29VTVJB?oc=5","date":"2026-02-04","type":"trial","source":"PR Newswire","summary":"Oncolytic Virus Clinical Trial Landscape Gains Momentum: 100+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight - PR Newswire","headline":"Oncolytic Virus Clinical Trial Landscape Gains Momentum: 100+ Companies Lead the Charge in Pioneering New Treatments | D","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxPc1pUTWp1XzliNUc2TTRkZ1BCc256VmFzNzk0bDEyak42M2lCRHVWMFFQQkJFX3BaUXYtTHFvQTZhQlVIekM0dEpYR3B5MldvOUFzWko0Yl9KVXdCaDZyUGZUZG5ENzNKQzNjV1E4TWdpRENkRkwxVG1ka2J2bFBCT3YwSE9saElLYUttWU1VVXVQZC1yNzRnUXU5ekk5ZEVMaVFrNmYxa3pwSnVqaWtMRGZGOURQQU83NTFxOQ?oc=5","date":"2025-12-12","type":"regulatory","source":"Proactive financial news","summary":"FDA backs Imugene’s azer-cel treatment plan - ICYMI - Proactive financial news","headline":"FDA backs Imugene’s azer-cel treatment plan - ICYMI","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxNMHlBODU4V2RzcnUybkFoWHo0RlViWG5vYmQwYlNOZ1gwUXh6bDl0OHJuWFFFSnhYTkRsSDBJLTdPSHpUVnVnTFljZjZPV3ZaNnFzX3EwVHBlUUtXU1R6c0ZuZXRoZlpkOHVsRlRFNFF5X1otRjdhb1dKSDlZcmdCRDMyOU9XT3BrSXZSQjROZFFTZzdGSWFKT0w0WVRJRXJKRWVpX0NQSUhoVUlKLTdSeUhXRmZKNHV6?oc=5","date":"2025-12-08","type":"pipeline","source":"The Motley Fool Australia","summary":"Why Artrya, Clinuvel, Imugene, and Pilbara Minerals shares are storming higher today - The Motley Fool Australia","headline":"Why Artrya, Clinuvel, Imugene, and Pilbara Minerals shares are storming higher today","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibEFVX3lxTE9DcTZIQjB5eV9ELVNYMWhucTZ6TDRfX2FtRWI0bVYxcTdfQVRhaGk3SkJOUG5yV3VpU3dqUXlJRm9CZmFLaHIzTnhIVkt6cFhIS0NVSnRYUzQxdFF1dVhUcnhmRjlGd3V1a3N5cQ?oc=5","date":"2025-11-07","type":"regulatory","source":"Proactive financial news","summary":"Imugene prepares pivotal azer-cel trial with FDA - ICYMI - Proactive financial news","headline":"Imugene prepares pivotal azer-cel trial with FDA - ICYMI","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0wFBVV95cUxNNS1zb3I3YmVvV0RMZnNqdU1pMmdnRDJaNE9PSk50SnpQTTdvbEdJZURuMUMyUTVNeUcyWHAwZnF0S05fMW5nRkRXYUZseDRxc24wNFB6R01TYlFpTHUtUl9senZyaGtLNmtnUWFWbW93cUFsVEp4UWF5dThyUWNFdDVZLWs1RTZmZVdjYlZsMjFGVDJDYmx2V0lsR3Z1UlpYWGoxMDZVRFJjUUlKS2s3TzVUa1pvUEV0TGFaWjhKNUNjNzdSbGx0TWxWMWpfbmtQeVhj?oc=5","date":"2025-09-17","type":"trial","source":"Proactive financial news","summary":"Imugene lifts response rate to 81% in azer-cel CAR T Phase 1b trial - Proactive financial news","headline":"Imugene lifts response rate to 81% in azer-cel CAR T Phase 1b trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxNd0RFQ2dsVGJzTnJWekMtaFlmcUhiT1NuRVhqbzIwTTRGRFd2QW8tMUFqa2JuZnFMSlBneVdjbTZxZnhFV0t5MkQ2YjBKT0dDYk9jV3U2R0JHX3NtU0JKNjdLMk9HQW1BanBTRVMxZU52aHVCTGRKUUE4M0VvbldKWUs3dkhyQVlKSC1uS0NvbzlJLXR0ZGxGZDVvWms4Y1puZHAyWVdiLWF2aDZmWWNwUXYyREZPQQ?oc=5","date":"2025-08-04","type":"pipeline","source":"Proactive financial news","summary":"Imugene’s Leslie Chong talks Azer-cel breakthrough - Proactive financial news","headline":"Imugene’s Leslie Chong talks Azer-cel breakthrough","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_gFBVV95cUxNeS1KcmR5T1RETG9pNlFXQkNrMDhMeU1RNlBzNFFad2pQZGJHel9falVudy15X0pCM1RDOWRTNTVHbzZEZmV4U21WNUJiMzNWZkZHcUJYVjRCUnAxVnRkZ1BRVkxBbXhiejJvTDR3ZVpJUWNtbTVCb3JvSkFINXpLcFM0OWVjc0ZDWWlXcHY1UmZObE9wUkZzVjJTbHAtWnotLUdwa2k1cUEyRVZieTRsSkFTeXRMbllBZjF6bHM0azRiYmpobHNvTDQ3bWpjT1k0VnRVMXNJbXd6cWctVm1xSVdCS2hERkdzaGJRNWh4MTVxWFBFbnJhenlOOWRVZw?oc=5","date":"2025-07-14","type":"trial","source":"PR Newswire","summary":"Imugene Announces Outstanding Response Rates from the Phase 1b Trial of the Azer-cel Allogeneic CAR T in 3L+ DLBCL - PR Newswire","headline":"Imugene Announces Outstanding Response Rates from the Phase 1b Trial of the Azer-cel Allogeneic CAR T in 3L+ DLBCL","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7wFBVV95cUxQV0dxSHFLTmZZYU5zNlJtYTgzdDFYaExZUGd5WmFFTmRZZ3N4TFRfRlNkcl95aUJsM0xZNTZSb19JeW1XMUtId19rRnd0Q0NXRzRIR2RmZWZqM2M3eV8wbkJzV2VQV2Z3QWotM0RZcEUxVGwtbDRvbmZQU3UxVnZzU0lKZkJWY3RsVklHYjE3bGdObDJqSFZtTnN0S2FKazBnQk9Wb21wc0JYaHlpOWFXVE5kMmZqWWNtT1pDM1ZXV2VHalYxZE90WncxSllxVTRFS0lONWdGUEdJWXNVSW01V245Njk5TUtmVW81dXlGOA?oc=5","date":"2025-06-05","type":"trial","source":"CRISPR Medicine News","summary":"Press Release Service: Oncolytic Virus Immunotherapy Strategic Research Business Report 2025-2030: Surge in Clinical Trials Combining Oncolytic Viruses With Checkpoint Inhibitors Expands Therapeutic H","headline":"Press Release Service: Oncolytic Virus Immunotherapy Strategic Research Business Report 2025-2030: Surge in Clinical Tri","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxObzF3ODhldERaeDkzLTFMdHViM0FWTV9Gb2dIQUNVSV8yajFvSVZhQzA5dFQtbUlpRTAxTUIyLVRsTG5IRmYtYm0wRmpYS1VjeHJQbTBSNU9DUHNwQjI3NVpuWGR2QURMQmduVng1Q2dOYk5VUFFVeW5mbGtnSE4yLTVzamM3YjNwTVZEMWNwZHNLR1lGdHRpX1BaalEzLXA5NEpkVTY5OEJUMnExMjVsdVBhcGF4RWdEOUVmQVlWSWVWUktGM21J?oc=5","date":"2024-12-12","type":"pipeline","source":"BioPharma APAC","summary":"RenovoRx and Imugene Join Forces for Oncolytic Virus Therapy Using TAMP Platform - BioPharma APAC","headline":"RenovoRx and Imugene Join Forces for Oncolytic Virus Therapy Using TAMP Platform","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxOU0FUNWVhNzQ1amI2N0ktYmsyWF90QzdoV09TaWZhTWkyUk5val93YTMyOTljbXJNSGNsLXBsZHpfb1U5Q2p6ZXB5T3FSeG5QN2lBbko4RjRXRzhTZUxLUnBLbWZRVEs5YkZnem1nN1hmWFRyUm9mYjZlYks0NFduLTRTWGFrTURhelNJMnMtcnJiQzdaTG5MSlNpNUlvcFlva09Wa0U2aU1VMHB4NWZr?oc=5","date":"2024-10-15","type":"pipeline","source":"Business Wire","summary":"Lucy Therapeutics Appoints Kim Drapkin as Board Chair - Business Wire","headline":"Lucy Therapeutics Appoints Kim Drapkin as Board Chair","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}